Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Medicis Pharmaceutical (MRX) Earnings Date, Estimates & Call Transcripts

Medicis Pharmaceutical logo

Medicis Pharmaceutical Latest Earnings Summary

Actual EPS
(Mar. 6)
$0.76 Beat By $0.12
Consensus EPS
(Mar. 6)
$0.64

Medicis Pharmaceutical released Q4 2024 earnings on March 6, 2025, reporting an EPS of $0.76, which beat the consensus estimate of $0.64 by $0.12. With a trailing EPS of $0.00, Medicis Pharmaceutical's earnings are expected to decrease -0.34% next year, from $2.94 to $2.93 per share.

Get Medicis Pharmaceutical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medicis Pharmaceutical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Medicis Pharmaceutical Analyst EPS Estimates

Current Year EPS Consensus Estimate:$2.94 EPS
Next Year EPS Consensus Estimate: $2.93 EPS
Remove Ads

Medicis Pharmaceutical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/6/2025Q4 2024$0.64$0.76+$0.12---
11/7/2024Q3 2024$0.68$0.76+$0.08$0.79$378.62M$391.20M
8/14/2024Q2 2024$0.53$0.90+$0.37$1.04$351.91M$422.10M

Medicis Pharmaceutical Earnings - Frequently Asked Questions

Medicis Pharmaceutical (NYSE:MRX) last announced its quarterly earning data on Thursday, March 6, 2025. Learn more on MRX's earnings history.

Medicis Pharmaceutical issued an update on its first quarter 2025 earnings guidance on Wednesday, April, 2nd. The company issued revenue guidance of $449.3 million-$464.3 million, compared to the consensus revenue estimate of $432.6 million.

In the previous quarter, Medicis Pharmaceutical (NYSE:MRX) reported $0.76 earnings per share (EPS) to beat the analysts' consensus estimate of $0.64 by $0.12. Learn more on analysts' earnings estimate vs. MRX's actual earnings.

The conference call for Medicis Pharmaceutical's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Medicis Pharmaceutical's latest earnings report can be read online.
Read Transcript

Medicis Pharmaceutical (NYSE:MRX) has a recorded annual revenue of $1.24 billion.

Medicis Pharmaceutical (NYSE:MRX) has a recorded net income of $141.30 million. MRX has generated $0.00 earnings per share over the last four quarters.

Medicis Pharmaceutical's earnings are expected to decrease from $2.94 per share to $2.93 per share in the next year, which is a -0.34% change.

More Earnings Resources from MarketBeat

Remove Ads


This page (NYSE:MRX) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners